Oncology Institute director receives RSU stock award

McGeorge Anne reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

McGeorge Anne reported acquisition or exercise transactions in this Form 4 filing.

Oncology Institute, Inc. reported that director Anne McGeorge received a grant of 41,165 restricted stock units (RSUs) of common stock. Each RSU entitles her to one share upon settlement and vests in full on the date of the company’s 2027 annual meeting of stockholders, subject to her continued service. Following this award, her direct holdings total 332,535 shares of common stock.

Insider Trade Summary

Grant/Award: 41,165 shares

Grant/Award 1 txn

Insider McGeorge Anne

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	41,165	$0.00	$0.00

Holdings After Transaction: Common Stock — 332,535 shares (Direct)

Footnotes (1)

1. F1. Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.

Key Figures

RSUs granted: 41,165 shares Grant price per share: $0.0000 per share Holdings after transaction: 332,535 shares

3 metrics

RSUs granted 41,165 shares Grant of restricted stock units to director Anne McGeorge

Grant price per share $0.0000 per share Reported transaction price for the RSU award

Holdings after transaction 332,535 shares Total direct common stock holdings of Anne McGeorge after the grant

Key Terms

restricted stock units, settlement, vest in full, annual meeting of stockholders

4 terms

restricted stock units financial

"Represents grant of restricted stock units (RSUs), each of which entitle"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

settlement financial

"entitle the Reporting Person to receive one share ... upon settlement."

Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.

vest in full financial

"The RSUs vest in full on the date of the Issuer's 2027 annual"

annual meeting of stockholders financial

"on the date of the Issuer's 2027 annual meeting of stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider equity award did Oncology Institute (TOI) report for Anne McGeorge?

Oncology Institute, Inc. reported that director Anne McGeorge received a grant of 41,165 restricted stock units (RSUs). Each RSU converts into one share of common stock upon settlement, increasing her direct holdings to 332,535 shares after the award.

What are the vesting terms of Anne McGeorge’s RSU grant at TOI?

The 41,165 RSUs granted to Anne McGeorge vest in full on the date of Oncology Institute’s 2027 annual meeting of stockholders. Vesting is conditioned on her continued service with the company through that meeting date.

How many shares of TOI common stock does Anne McGeorge hold after this grant?

After the RSU award, Anne McGeorge directly holds 332,535 shares of Oncology Institute, Inc. common stock. This total includes the 41,165 restricted stock units, each scheduled to settle into one share upon vesting and settlement.

What type of security was granted to TOI director Anne McGeorge?

Anne McGeorge received a grant of restricted stock units (RSUs), linked one-for-one to Oncology Institute common shares. The filing specifies that each RSU entitles her to receive one share of common stock upon settlement, subject to the vesting conditions.

Was the RSU grant to TOI director Anne McGeorge made at a cash purchase price?

No cash purchase was involved; the RSU grant lists a price of $0.0000 per share. This reflects a compensatory equity award rather than an open-market stock purchase, consistent with typical director compensation structures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/29/2026 - 06:54 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McGeorge Anne

(Last) (First) (Middle)

C/O THE ONCOLOGY INSTITUTE INC.

18000 STUDEBAKER RD, SUITE 800

(Street)

CERRITOS CALIFORNIA 90703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Oncology Institute, Inc. [ TOI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/27/2026		A(1)		41,165	A	$0.00	332,535	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date.

	/s/ Mark Hueppelsheuser, Attorney-in-Fact for Anne McGeorge	07/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)